SEMG1 Antikörper (AA 24-310)
Kurzübersicht für SEMG1 Antikörper (AA 24-310) (ABIN7168831)
Target
Alle SEMG1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 24-310
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Semenogelin-1 protein (24-310AA)
-
Isotyp
- IgG
-
-
anti-Semenogelin I (SEMG1) (AA 51-100) antibody
SEMG1 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (N-Term) antibodySEMG1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (N-Term) antibodySEMG1 Reaktivität: Human, Schwein WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (C-Term) antibodySEMG1 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (AA 24-462) antibodySEMG1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (AA 24-310) antibodySEMG1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (AA 1-402) antibodySEMG1 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (AA 301-350) antibodySEMG1 Reaktivität: Human, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (AA 251-300) antibodySEMG1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Semenogelin I (SEMG1) (C-Term) antibodySEMG1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SEMG1 (Semenogelin I (SEMG1))
-
Andere Bezeichnung
- SEMG1
-
Hintergrund
-
Background: Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. Alpha-inhibin-92 and alpha-inhibin-31, derived from the proteolytic degradation of semenogelin, inhibit the secretion of pituitary follicle-stimulating hormone.1 Publication
Aliases: Alpha-Inhibin-31 antibody, Alpha-Inhibin-92 antibody, Cancer/testis antigen 103 antibody, CT103 antibody, dJ172H20.2 (semenogelin I) antibody, dJ172H20.2 antibody, MGC14719 antibody, Semen coagulating protein antibody, Semenogelin antibody, Semenogelin I antibody, SEMG antibody, SEMG1 antibody, SEMG1_HUMAN antibody, Seminal basic protein antibody, seminal vesicle secretory protein 5 antibody, SgI antibody, Svp-1 antibody, Svp5 antibody, SVPIIA antibody, Svs2 antibody, SVS2P antibody, Svs2p2 antibody, Svs5 antibody
-
UniProt
- P04279
Target
-
